ELEVANCE HEALTH, INC. Increase (Decrease) in Accounts Payable and Other Operating Liabilities
ELEVANCE HEALTH, INC. (ELV) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of $4.12 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-07-15
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-06-30 was $1.24B, a 67.75% increase year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-03-31 was $2.89B, a 203.15% increase year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-12-31 was -$2.26B.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-09-30 was -$151.00M, a 124.04% decline year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was -$720.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was -$272.00M, a 116.59% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was $1.64B, a 99.03% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2022 was $824.00M, a 14.60% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.24B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $4.12B 10-Q · filed 2026-07-15 | $1.86B derived: sum of 3 quarters · filed 2026-07-15 | $1.71B derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-03-31 | $2.89B 10-Q · filed 2026-04-22 | $627.00M derived: sum of 2 quarters · filed 2026-04-22 | $476.00M derived: sum of 3 quarters · filed 2026-04-22 | $1.21B derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-12-31 | -$2.26B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$2.41B derived: sum of 2 quarters · filed 2026-02-06 | -$1.67B derived: sum of 3 quarters · filed 2026-07-15 | -$720.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | -$151.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $587.00M derived: sum of 2 quarters · filed 2026-07-15 | $1.54B 10-Q · filed 2025-10-21 | $339.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-06-30 | $738.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $1.69B 10-Q · filed 2026-07-15 | $490.00M derived: sum of 3 quarters · filed 2026-07-15 | $1.12B derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-03-31 | $952.00M 10-Q · filed 2026-04-22 | -$248.00M derived: sum of 2 quarters · filed 2026-04-22 | $380.00M derived: sum of 3 quarters · filed 2026-04-22 | $937.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | -$1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$572.00M derived: sum of 2 quarters · filed 2026-02-06 | -$15.00M derived: sum of 3 quarters · filed 2026-02-06 | -$272.00M 10-K · filed 2026-02-06 |
| 2024-09-30 | $628.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $1.19B derived: sum of 2 quarters · filed 2025-10-21 | $928.00M 10-Q · filed 2025-10-21 | $851.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $557.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-17 | $300.00M 10-Q · filed 2025-07-17 | $223.00M derived: sum of 3 quarters · filed 2026-02-06 | $1.78B derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | -$257.00M 10-Q · filed 2025-04-22 | -$334.00M derived: sum of 2 quarters · filed 2026-02-06 | $1.22B derived: sum of 3 quarters · filed 2026-02-06 | $1.36B derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | -$77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.48B derived: sum of 2 quarters · filed 2026-02-06 | $1.62B derived: sum of 3 quarters · filed 2026-02-06 | $1.64B 10-K · filed 2026-02-06 |
| 2023-09-30 | $1.56B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-17 | $1.70B derived: sum of 2 quarters · filed 2024-10-17 | $1.72B 10-Q · filed 2024-10-17 | $1.94B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $142.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-17 | $160.00M 10-Q · filed 2024-07-17 | $386.00M derived: sum of 3 quarters · filed 2025-02-20 | $352.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $18.00M 10-Q · filed 2024-04-18 | $244.00M derived: sum of 2 quarters · filed 2025-02-20 | $210.00M derived: sum of 3 quarters · filed 2025-02-20 | $414.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $226.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $192.00M derived: sum of 2 quarters · filed 2025-02-20 | $396.00M derived: sum of 3 quarters · filed 2025-02-20 | $824.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$34.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-10-18 | $170.00M derived: sum of 2 quarters · filed 2023-10-18 | $598.00M 10-Q · filed 2023-10-18 | $224.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $204.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-09-29 | $632.00M 10-Q/A · filed 2023-09-29 | $258.00M derived: sum of 3 quarters · filed 2024-02-21 | $791.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $428.00M 10-Q · filed 2023-04-19 | $54.00M derived: sum of 2 quarters · filed 2024-02-21 | $587.00M derived: sum of 3 quarters · filed 2024-02-21 | $789.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$374.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $159.00M derived: sum of 2 quarters · filed 2024-02-21 | $361.00M derived: sum of 3 quarters · filed 2024-02-21 | $719.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | $533.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-19 | $735.00M derived: sum of 2 quarters · filed 2022-10-19 | $1.09B 10-Q · filed 2022-10-19 | $1.12B derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-06-30 | $202.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $560.00M 10-Q · filed 2022-07-20 | $585.00M derived: sum of 3 quarters · filed 2023-10-18 | $670.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-03-31 | $358.00M 10-Q · filed 2022-04-20 | $383.00M derived: sum of 2 quarters · filed 2023-10-18 | $468.00M derived: sum of 3 quarters · filed 2023-10-18 | $1.75B derived: sum of 4 quarters · filed 2023-10-18 |
| 2020-12-31 | $25.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $110.00M derived: sum of 2 quarters · filed 2023-10-18 | $1.39B derived: sum of 3 quarters · filed 2023-10-18 | $1.98B 10-Q · filed 2023-10-18 |
| 2020-09-30 | $85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $1.36B derived: sum of 2 quarters · filed 2021-10-20 | $1.95B 10-Q · filed 2021-10-20 | $1.76B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $1.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $1.87B 10-Q · filed 2021-07-21 | $1.68B derived: sum of 3 quarters · filed 2022-02-16 | $1.81B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $588.00M 10-Q · filed 2021-04-21 | $399.00M derived: sum of 2 quarters · filed 2022-02-16 | $526.00M derived: sum of 3 quarters · filed 2022-02-16 | $497.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$189.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$62.00M derived: sum of 2 quarters · filed 2022-02-16 | -$91.00M derived: sum of 3 quarters · filed 2022-02-16 | -$445.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $98.00M derived: sum of 2 quarters · filed 2020-10-28 | -$256.00M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | -$29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$383.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | -$354.00M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $97.00M 10-K · filed 2021-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |